Extending the age eligibility for seasonal malaria chemoprevention to children aged 5-10 years is generally regarded as acceptable by key informants in Massaguet district, Chad.n Decision makers at the policy level consider it more urgent to achieve full coverage, demonstrate impact, and ensure the sustainability of SMC administration in children aged 3-59 months in the current program.